Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Two Day Pharmaceutical Regulatory Affairs in China Seminar (Basel, Switzerland - November 24th-25th, 2016) - Research and Markets

Research and Markets
Posted on: 07 Oct 16

Research and Markets has announced the addition of the "Pharmaceutical Regulatory Affairs in China" conference to their offering.

This seminar will provide a detailed overview of the key areas of pharmaceutical regulatory affairs in China, Hong Kong, Macau and Taiwan and will cover ll important aspects of gaining and maintaining a successful Marketing Authorisation in the region

- Drug regulatory systems

- An overview of import and local manufacture registration

- Clinical product development including CMC regulatory requirements

- An interpretation of practical aspects

- Recent developments

- The opportunity to exchange experiences with other delegates

Agenda

Programme Day One

General Introduction to Peoples Republic of China and the Pharmaceutical Market

- Commercial and Cultural Background

Drug Regulatory Systems

- Regulatory Authorities

- Regulations and Guidelines

- Drug Classification Systems

- Import and local manufacture registration

- Data requirements

- Registration requirements

- Labelling requirements

Clinical Product Development

- Regulatory aspects of clinical development

- Documentation needs including CMC

- Regulatory requirements including GCP aspects

- Chinese specific approaches

- Multinational Clinical Trials

Hong Kong SAR

- Background Overview

- Regulatory Authorities

- Regulatory Requirements and Procedures

- Specific market aspects

Macau SAR

- Brief overview of regulatory aspects

Discussion Session

Programme Day Two

P.R. China

- Product Registration Strategies

- - Summary information contrasting import and local manufacture registrations

- - Planning to meet documentation requirements

- - Expediting regulatory approvals

- CMC specific matters

- - CMC regulatory requirements

- - Current standards and future trends

- Variations and Renewals

- - Regulatiory procedures

- Documentation expectations

Taiwan (Republic of China)

- Cultural Background

- Regulatory Authorities

- Regulation and Guidelines

- Drug Classifications Systems

- Data Requirements

- Country specific matters

P.R. China

- Health Authorities Interactions

- Recent Regulatory Developments

Final Discussion

Summary and conclusions of the Seminar

For more information about this conference visit http://www.researchandmarkets.com/research/rlm84j/pharmaceutical

View source version on businesswire.com: http://www.businesswire.com/news/home/20161007005413/en/

Business Wire
www.businesswire.com

Last updated on: 07/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.